BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 30.08.1995

Drug Export; Anzemet (Dolasetron Mesilate) Bulk Drug Substance

The Food and Drug Administration (FDA) is announcing that Marian Merrell Dow Inc., has filed an application requesting conditional approval for the export of Anzemet (dolasetron Mesilate) Bulk Drug Substance to Italy for the preparation and packaging of the following injectable dose strengths 12.5 milligrams (mg), 25 mg, 50 mg, 100 mg, and 200 mg for transshipment to the United Kingdom.

Source: Federal Register — Food and Drug AdministrationOpen original release →